Exxon Mobil Value Added Proposition

First Page		Document Content
Date: 2012-06-26 09:47:50 Chemistry Pharmacokinetics Pharmacy Toxicology Physiologically based pharmacokinetic modelling Toxicokinetics Biomonitoring Toxicity Quantitative structure–activity relationship Pharmaceutical sciences Medicine Pharmacology		Exxon Mobil Value Added Proposition Add to Reading List Source URL: www.axlr8.eu Download Document from Source Website File Size: 1,44 MB Share Document on Facebook

	Identifying Structure-Activity Cliffs in a Salmonella QSAR Model for Predicting the Potential Mutagenicity of Genotoxic Drug Impurities and Other Organic Molecules P46 Kevin P. Cross1, R. Daniel Benz2, Lidiya Stavitskay DocID: 1ptdl - View Document
	Mapping the Human Toxome by Systems Toxicology Using ED as Proof of Concept Thomas Hartung Doerenkamp-Zbinden Professor and Chair for Evidence-based Toxicology, EHS Director, Center for Alternatives to Animal Testing (CA DocID: 1fRGs - View Document
	Data Mining in Bioinformatics Day 8: Graph Mining for Chemoinformatics and Drug Discovery Chloé-Agathe Azencott Machine Learning & Computational Biology Research Group MPIs Tübingen DocID: 1fB0S - View Document
	QSAR Applicability Domain (AD) assessment Substance: CASisobutyl dihydrogen phosphate) According to QSAR Applicability Domain (AD) assessment the fully documented and REACH compliant QSAR reports are availabl DocID: 1fyud - View Document
	Final Report Effects of Molecular and Environmental Properties on Removal of Pharmaceuticals, Endocrine Disruptors and Disinfection Byproducts by Polyamide RO Membranes Submitted by: Orange County Water District DocID: 1aZLS - View Document